Tafenoquine is an aminoquinoline that is used in combination with other antimalarials for the prevention of relapse of Plasmodium vivax malaria and by itself as prophylaxis against all species of malaria. Tafenoquine has been linked to low rates of transient and asymptomatic serum enzyme elevations during therapy but has not been associated with instances of clinically apparent acute liver injury.
The global Tafenoquine market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029.
Key manufacturers engaged in the Tafenoquine industry include GlaxoSmithKline Pharmaceuticals (GSK), J & K Scientific LTD, BOC Sciences, WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd., Pharmacodia (Beijing) Co.,Ltd, Amadis Chemical Company Limited and Merck, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Tafenoquine were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Tafenoquine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Tafenoquine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
GlaxoSmithKline Pharmaceuticals (GSK)
J & K Scientific LTD
BOC Sciences
WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
Pharmacodia (Beijing) Co.,Ltd
Amadis Chemical Company Limited
Merck
Segment by Type
Powder
Pills
Segment by Application
Radical Cure of P.vivax
P. falciparum Treatment
Prevention of Malaria Relapse
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Tafenoquine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Tafenoquine Market Overview
1.1 Product Overview and Scope of Tafenoquine
1.2 Tafenoquine Segment by Type
1.2.1 Global Tafenoquine Market Value Comparison by Type (2023-2029)
1.2.2 Powder
1.2.3 Pills
1.3 Tafenoquine Segment by Application
1.3.1 Global Tafenoquine Market Value by Application: (2023-2029)
1.3.2 Radical Cure of P.vivax
1.3.3 P. falciparum Treatment
1.3.4 Prevention of Malaria Relapse
1.4 Global Tafenoquine Market Size Estimates and Forecasts
1.4.1 Global Tafenoquine Revenue 2018-2029
1.4.2 Global Tafenoquine Sales 2018-2029
1.4.3 Global Tafenoquine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Tafenoquine Market Competition by Manufacturers
2.1 Global Tafenoquine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Tafenoquine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Tafenoquine Average Price by Manufacturers (2018-2023)
2.4 Global Tafenoquine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Tafenoquine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tafenoquine, Product Type & Application
2.7 Tafenoquine Market Competitive Situation and Trends
2.7.1 Tafenoquine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Tafenoquine Players Market Share by Revenue
2.7.3 Global Tafenoquine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Tafenoquine Retrospective Market Scenario by Region
3.1 Global Tafenoquine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Tafenoquine Global Tafenoquine Sales by Region: 2018-2029
3.2.1 Global Tafenoquine Sales by Region: 2018-2023
3.2.2 Global Tafenoquine Sales by Region: 2024-2029
3.3 Global Tafenoquine Global Tafenoquine Revenue by Region: 2018-2029
3.3.1 Global Tafenoquine Revenue by Region: 2018-2023
3.3.2 Global Tafenoquine Revenue by Region: 2024-2029
3.4 North America Tafenoquine Market Facts & Figures by Country
3.4.1 North America Tafenoquine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Tafenoquine Sales by Country (2018-2029)
3.4.3 North America Tafenoquine Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Tafenoquine Market Facts & Figures by Country
3.5.1 Europe Tafenoquine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Tafenoquine Sales by Country (2018-2029)
3.5.3 Europe Tafenoquine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tafenoquine Market Facts & Figures by Country
3.6.1 Asia Pacific Tafenoquine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Tafenoquine Sales by Country (2018-2029)
3.6.3 Asia Pacific Tafenoquine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Tafenoquine Market Facts & Figures by Country
3.7.1 Latin America Tafenoquine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Tafenoquine Sales by Country (2018-2029)
3.7.3 Latin America Tafenoquine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tafenoquine Market Facts & Figures by Country
3.8.1 Middle East and Africa Tafenoquine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Tafenoquine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Tafenoquine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tafenoquine Sales by Type (2018-2029)
4.1.1 Global Tafenoquine Sales by Type (2018-2023)
4.1.2 Global Tafenoquine Sales by Type (2024-2029)
4.1.3 Global Tafenoquine Sales Market Share by Type (2018-2029)
4.2 Global Tafenoquine Revenue by Type (2018-2029)
4.2.1 Global Tafenoquine Revenue by Type (2018-2023)
4.2.2 Global Tafenoquine Revenue by Type (2024-2029)
4.2.3 Global Tafenoquine Revenue Market Share by Type (2018-2029)
4.3 Global Tafenoquine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Tafenoquine Sales by Application (2018-2029)
5.1.1 Global Tafenoquine Sales by Application (2018-2023)
5.1.2 Global Tafenoquine Sales by Application (2024-2029)
5.1.3 Global Tafenoquine Sales Market Share by Application (2018-2029)
5.2 Global Tafenoquine Revenue by Application (2018-2029)
5.2.1 Global Tafenoquine Revenue by Application (2018-2023)
5.2.2 Global Tafenoquine Revenue by Application (2024-2029)
5.2.3 Global Tafenoquine Revenue Market Share by Application (2018-2029)
5.3 Global Tafenoquine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 GlaxoSmithKline Pharmaceuticals (GSK)
6.1.1 GlaxoSmithKline Pharmaceuticals (GSK) Corporation Information
6.1.2 GlaxoSmithKline Pharmaceuticals (GSK) Description and Business Overview
6.1.3 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Product Portfolio
6.1.5 GlaxoSmithKline Pharmaceuticals (GSK) Recent Developments/Updates
6.2 J & K Scientific LTD
6.2.1 J & K Scientific LTD Corporation Information
6.2.2 J & K Scientific LTD Description and Business Overview
6.2.3 J & K Scientific LTD Tafenoquine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 J & K Scientific LTD Tafenoquine Product Portfolio
6.2.5 J & K Scientific LTD Recent Developments/Updates
6.3 BOC Sciences
6.3.1 BOC Sciences Corporation Information
6.3.2 BOC Sciences Description and Business Overview
6.3.3 BOC Sciences Tafenoquine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 BOC Sciences Tafenoquine Product Portfolio
6.3.5 BOC Sciences Recent Developments/Updates
6.4 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
6.4.1 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Corporation Information
6.4.2 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Description and Business Overview
6.4.3 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Product Portfolio
6.4.5 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Recent Developments/Updates
6.5 Pharmacodia (Beijing) Co.,Ltd
6.5.1 Pharmacodia (Beijing) Co.,Ltd Corporation Information
6.5.2 Pharmacodia (Beijing) Co.,Ltd Description and Business Overview
6.5.3 Pharmacodia (Beijing) Co.,Ltd Tafenoquine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Pharmacodia (Beijing) Co.,Ltd Tafenoquine Product Portfolio
6.5.5 Pharmacodia (Beijing) Co.,Ltd Recent Developments/Updates
6.6 Amadis Chemical Company Limited
6.6.1 Amadis Chemical Company Limited Corporation Information
6.6.2 Amadis Chemical Company Limited Description and Business Overview
6.6.3 Amadis Chemical Company Limited Tafenoquine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Amadis Chemical Company Limited Tafenoquine Product Portfolio
6.6.5 Amadis Chemical Company Limited Recent Developments/Updates
6.7 Merck
6.6.1 Merck Corporation Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Tafenoquine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Merck Tafenoquine Product Portfolio
6.7.5 Merck Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tafenoquine Industry Chain Analysis
7.2 Tafenoquine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tafenoquine Production Mode & Process
7.4 Tafenoquine Sales and Marketing
7.4.1 Tafenoquine Sales Channels
7.4.2 Tafenoquine Distributors
7.5 Tafenoquine Customers
8 Tafenoquine Market Dynamics
8.1 Tafenoquine Industry Trends
8.2 Tafenoquine Market Drivers
8.3 Tafenoquine Market Challenges
8.4 Tafenoquine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
GlaxoSmithKline Pharmaceuticals (GSK)
J & K Scientific LTD
BOC Sciences
WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
Pharmacodia (Beijing) Co.,Ltd
Amadis Chemical Company Limited
Merck
*If Applicable.